Tiziana Life Sciences (TLSA) Enterprise Value (2018 - 2025)

Tiziana Life Sciences has reported Enterprise Value for 8 years, with the latest figure at $175.5 million in Q4 2025.

• On a quarterly basis, Enterprise Value rose 136.27% year-over-year to $175.5 million in Q4 2025; TTM through Dec 2025 was $175.5 million, a 136.27% increase from a year earlier, with the FY2025 full-year figure at $175.5 million, up 136.27% from the prior year.
• Enterprise Value was $175.5 million for Q4 2025 at Tiziana Life Sciences, up from $168.9 million in the prior quarter.
• The five-year high for Enterprise Value was $404.1 million in Q2 2021, with the low at $43.2 million in Q4 2022.
• Average Enterprise Value over 5 years is $118.5 million, with a median of $68.6 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Enterprise Value slumped 87.59% in 2022, then soared 136.27% in 2025.
• Over 5 years, Enterprise Value stood at $56.0 million in 2021, then retreated by 22.78% to $43.2 million in 2022, then jumped by 30.77% to $56.5 million in 2023, then soared by 31.4% to $74.3 million in 2024, then jumped by 136.27% to $175.5 million in 2025.
• The last three Enterprise Value figures came in at $175.5 million (Q4 2025), $168.9 million (Q2 2025), and $74.3 million (Q4 2024), per Business Quant data.